TBI-1301 (NY-ESO-1 TCR Gene Therapy)
Synovial Sarcoma, Myxoid/Round Cell Liposarcoma
Phase 1/2Active
Key Facts
Indication
Synovial Sarcoma, Myxoid/Round Cell Liposarcoma
Phase
Phase 1/2
Status
Active
Company
About Takara Bio
Takara Bio is a global biotechnology company with a mission to contribute to the advancement of life sciences and the improvement of human health. It has established itself as a key provider of research reagents, instruments, and contract development and manufacturing (CDMO) services, particularly in the fields of cell and gene therapy. The company's strategic direction focuses on expanding its therapeutic pipeline, scaling its CDMO capabilities, and deepening its research tools portfolio to address growing market demands in precision medicine.
View full company profile